Lama Elbahlawan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lama Elbahlawan has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Cheng Cheng
Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN, United States
7 shared publicationsR. Ray Morrison
Division of Critical Care Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
5 shared publicationsEmily Ashcraft
Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN, United States
4 shared publications- Amr Qudeimat
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
3 shared publications John Bissler
Le Bonheur Children’s Hospital, University of Tennessee Health Science Center
3 shared publicationsYvonne Avent
Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children’s Research Hospital
3 shared publications
Latest Publications
- Open Access
- 11 February 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1742467
Detecting Endothelial Compromise Objectively through Dynamic EASIX scoring (DECODE) - predictive utility of EASIX and modified EASIX scores for endothelial complications post hematopoietic cell transplant
Introduction: Endothelial injury is a major contributor to morbidity and mortality in pediatric patients undergoing hematopoietic cell transplantation (HCT). It appears as sinusoidal obstruction syndrome (SOS) or transplant-associated thrombotic microangiopathy (TMA), among other conditions. Composite indices like the Endothelial Activation and Stress Index (EASIX) and its modified version (m-EASIX) may serve as accessible biomarkers for early identification. However, their utility in pediatric populations is unestablished. We aimed to explore whether EASIX and m-EASIX can help identify endothelial complications in this setting. Methods: We conducted a prospective, single-center observational cohort study of 31 children and young adults undergoing HCT. Serial measurements of EASIX and m-EASIX scores, based on standard laboratory parameters, were collected at baseline and at multiple post-HCT time points (Days 0, 7, 14, 21, 28, and 100). Results: Within 100 days after HCT, SOS and/or TMA developed in six patients. At Day 21, EASIX and m-EASIX scores were significantly higher in children with endothelial complications than in controls. The m-EASIX score also showed predictive value at Day 14. Receiver operating characteristic analysis showed discrimination at Day 21 for both scores (AUCs of 0.807 for EASIX and 0.865 for m-EASIX). Changes from baseline to Day 21 further improved accuracy, with thresholds achieving high sensitivity for screening patients at increased risk of SOS and/or TMA. The Day 21 landmark is most relevant for identifying patients at risk of later-onset or persistent endothelial injury, which remains clinically significant. Conclusions: Our findings suggest that EASIX and m-EASIX may serve as practical and dynamic biomarkers for detecting endothelial injury in pediatric HCT recipients. The observation that Day 21 scores and their changes from baseline correlate with later complications highlights a potential window for risk stratification. However, these results should be interpreted cautiously, given the single-center design and limited sample size. Further research is needed to confirm whether these indices can reliably guide clinical decisions across diverse settings. Exploring their use in populations where reduced-intensity conditioning (RIC) and alternative donors are standard could provide important insights. Multicenter studies will be essential to validate these preliminary observations and refine biomarker-based strategies for post-HCT care.
- 11 February 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1742467
Open AccessDetecting Endothelial Compromise Objectively through Dynamic EASIX scoring (DECODE) - predictive utility of EASIX and modified EASIX scores for endothelial complications post hematopoietic cell transplant
Introduction: Endothelial injury is a major contributor to morbidity and mortality in pediatric patients undergoing hematopoietic cell transplantation (HCT). It appears as sinusoidal obstruction syndrome (SOS) or transplant-associated thrombotic microangiopathy (TMA), among other conditions. Composite indices like the Endothelial Activation and Stress Index (EASIX) and its modified version (m-EASIX) may serve as accessible biomarkers for early identification. However, their utility in pediatric populations is unestablished. We aimed to explore whether EASIX and m-EASIX can help identify endothelial complications in this setting. Methods: We conducted a prospective, single-center observational cohort study of 31 children and young adults undergoing HCT. Serial measurements of EASIX and m-EASIX scores, based on standard laboratory parameters, were collected at baseline and at multiple post-HCT time points (Days 0, 7, 14, 21, 28, and 100). Results: Within 100 days after HCT, SOS and/or TMA developed in six patients. At Day 21, EASIX and m-EASIX scores were significantly higher in children with endothelial complications than in controls. The m-EASIX score also showed predictive value at Day 14. Receiver operating characteristic analysis showed discrimination at Day 21 for both scores (AUCs of 0.807 for EASIX and 0.865 for m-EASIX). Changes from baseline to Day 21 further improved accuracy, with thresholds achieving high sensitivity for screening patients at increased risk of SOS and/or TMA. The Day 21 landmark is most relevant for identifying patients at risk of later-onset or persistent endothelial injury, which remains clinically significant. Conclusions: Our findings suggest that EASIX and m-EASIX may serve as practical and dynamic biomarkers for detecting endothelial injury in pediatric HCT recipients. The observation that Day 21 scores and their changes from baseline correlate with later complications highlights a potential window for risk stratification. However, these results should be interpreted cautiously, given the single-center design and limited sample size. Further research is needed to confirm whether these indices can reliably guide clinical decisions across diverse settings. Exploring their use in populations where reduced-intensity conditioning (RIC) and alternative donors are standard could provide important insights. Multicenter studies will be essential to validate these preliminary observations and refine biomarker-based strategies for post-HCT care.
- Open Access
- 9 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 7105
Unraveling the Easix Score: Its Association with Vasopressor Need in Critically Ill Septic Pediatric Hematology–Oncology Patients
Background: Sepsis is a common and serious complication in pediatric hematology oncology (PHO) patients. The Endothelial Activation and Stress Index (EASIX) score offers a potentially accessible tool for risk stratification in septic patients. Our objective was to evaluate the association of the EASIX score with adverse clinical outcomes among septic PHO patients. Methods: A retrospective review was conducted for all PHO patients admitted to the intensive care unit (ICU) with sepsis from July 2022 to December 2024. Results: A total of 53 patients with 65 sepsis events were included in this analysis. The median age was 14.9 [IQR 9.9] y and the most common disease was hematologic malignancy. In our cohort, 60% needed vasopressors, 36% required invasive mechanical ventilation, and 22% underwent renal replacement therapy (RRT). Log2-EASIX > 2.5 was associated with higher vasopressor requirements (87% versus 45% in the low log2-EASIX group, p = 0.001) and an increased need for RRT (39% versus 12%, p = 0.024). Septic PHO patients with log2-EASIX > 2.5 were 6.9 times more likely to require vasopressor support [(95% CI 1.7–27.8) p = 0.007]. In addition, PHO patients with log2-EASIX > 2.5 had a longer ICU stay (7 d versus 2 d in the low log2-EASIX group, p = 0.024) and an extended overall hospitalization (33 d versus 25 d, p = 0.029). Conclusions: A higher EASIX score was associated with adverse outcomes in critically ill septic PHO patients. Our findings suggest that the EASIX score can be used as a tool for identifying septic patients at an increased risk of clinical deterioration and poor outcomes. Prospective studies in larger cohorts are warranted to validate and expand upon these findings.
- 9 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 7105
Open AccessUnraveling the Easix Score: Its Association with Vasopressor Need in Critically Ill Septic Pediatric Hematology–Oncology Patients
Background: Sepsis is a common and serious complication in pediatric hematology oncology (PHO) patients. The Endothelial Activation and Stress Index (EASIX) score offers a potentially accessible tool for risk stratification in septic patients. Our objective was to evaluate the association of the EASIX score with adverse clinical outcomes among septic PHO patients. Methods: A retrospective review was conducted for all PHO patients admitted to the intensive care unit (ICU) with sepsis from July 2022 to December 2024. Results: A total of 53 patients with 65 sepsis events were included in this analysis. The median age was 14.9 [IQR 9.9] y and the most common disease was hematologic malignancy. In our cohort, 60% needed vasopressors, 36% required invasive mechanical ventilation, and 22% underwent renal replacement therapy (RRT). Log2-EASIX > 2.5 was associated with higher vasopressor requirements (87% versus 45% in the low log2-EASIX group, p = 0.001) and an increased need for RRT (39% versus 12%, p = 0.024). Septic PHO patients with log2-EASIX > 2.5 were 6.9 times more likely to require vasopressor support [(95% CI 1.7–27.8) p = 0.007]. In addition, PHO patients with log2-EASIX > 2.5 had a longer ICU stay (7 d versus 2 d in the low log2-EASIX group, p = 0.024) and an extended overall hospitalization (33 d versus 25 d, p = 0.029). Conclusions: A higher EASIX score was associated with adverse outcomes in critically ill septic PHO patients. Our findings suggest that the EASIX score can be used as a tool for identifying septic patients at an increased risk of clinical deterioration and poor outcomes. Prospective studies in larger cohorts are warranted to validate and expand upon these findings.
- 12 August 2025
- Published by Springer Nature
- p. 1023-1034
Renal Replacement Therapy in the Surgical Pediatric Oncology Patient
- 12 August 2025
- Published by Springer Nature
- p. 1023-1034
Renal Replacement Therapy in the Surgical Pediatric Oncology Patient
- Open Access
- 11 June 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1576639
Hypoalbuminemia is associated with adverse outcomes in critically ill children with cancer
Introduction: Acute kidney injury (AKI) is a serious complication encountered often in critically ill children with cancer. Hypoalbuminemia, commonly present in this population, has been associated with poor outcomes, including a higher rate of AKI. Studies examining the impact of hypoalbuminemia on outcomes in critically ill children with cancer are lacking. Therefore, the objective of this study was to investigate the impact of low serum albumin levels (SAL) on outcomes, including mortality and AKI, in critically ill children with oncologic/hematologic diseases. We also sought to examine the risk factors of AKI in this population.Methods: Retrospective review of all children with hematologic/oncologic disease admitted to the intensive care unit (ICU) from December 2020 to April 2021.Results: A total of 82 patients were included in this study cohort. The median age in our cohort was 10.3 y (0.8, 22.3), and the most common diagnosis was hematologic malignancy (41%). Thirty percent of the cohort experienced AKI; 30% of these cases were severe. Risk factors for AKI included sepsis, antiviral medications, higher nephrotoxicity index, and a higher number of nephrotoxic drugs. The rate of AKI was higher in children with SAL vs 27% in children with SAL ≥2.5 g/dL, P=0.09). SAL vs 2% in children with SAL≥3 g/dL, P=0.038) and a longer duration of ICU stay (4 days vs 2, P=0.028).Conclusion: Hypoalbuminemia is associated with adverse outcomes in children with oncologic/hematologic disease. Particularly, SAL < 3 g/dL are associated with higher need for IMV and longer ICU duration. Future studies are required to investigate the impact of hypoalbuminemia in this population and whether correcting hypoalbuminemia improves outcomes.
- 11 June 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1576639
Open AccessHypoalbuminemia is associated with adverse outcomes in critically ill children with cancer
Introduction: Acute kidney injury (AKI) is a serious complication encountered often in critically ill children with cancer. Hypoalbuminemia, commonly present in this population, has been associated with poor outcomes, including a higher rate of AKI. Studies examining the impact of hypoalbuminemia on outcomes in critically ill children with cancer are lacking. Therefore, the objective of this study was to investigate the impact of low serum albumin levels (SAL) on outcomes, including mortality and AKI, in critically ill children with oncologic/hematologic diseases. We also sought to examine the risk factors of AKI in this population.Methods: Retrospective review of all children with hematologic/oncologic disease admitted to the intensive care unit (ICU) from December 2020 to April 2021.Results: A total of 82 patients were included in this study cohort. The median age in our cohort was 10.3 y (0.8, 22.3), and the most common diagnosis was hematologic malignancy (41%). Thirty percent of the cohort experienced AKI; 30% of these cases were severe. Risk factors for AKI included sepsis, antiviral medications, higher nephrotoxicity index, and a higher number of nephrotoxic drugs. The rate of AKI was higher in children with SAL vs 27% in children with SAL ≥2.5 g/dL, P=0.09). SAL vs 2% in children with SAL≥3 g/dL, P=0.038) and a longer duration of ICU stay (4 days vs 2, P=0.028).Conclusion: Hypoalbuminemia is associated with adverse outcomes in children with oncologic/hematologic disease. Particularly, SAL < 3 g/dL are associated with higher need for IMV and longer ICU duration. Future studies are required to investigate the impact of hypoalbuminemia in this population and whether correcting hypoalbuminemia improves outcomes.
- Open Access
- 2 June 2025
- Published by Wiley
Easix score predicts the need for vasopressor support in critically ill pediatric hematology oncology patients
Background Sepsis is a common and serious complication in pediatric hematology oncology (PHO) patients. The Endothelial Activation and Stress Index (EASIX) score offers a potentially accessible tool for risk stratification in septic patients. Our objective was to evaluate the utility of the EASIX score in predicting adverse clinical outcomes among septic PHO patients. Methods Retrospective review of all PHO patients admitted to the intensive care unit (ICU) with sepsis from July 2022 till December 2024. Results 53 patients with 65 sepsis events were included in the analysis. The median age was 14.9 [IQR 9.9] y and the most common disease was hematologic malignancy (71%). In our cohort, 60% needed vasopressor support, 36% required IMV, and 22% underwent renal replacement therapy (RRT). Log2-EASIX >2.5 was associated with higher vasopressor requirements (87% versus 45% in the low log2-EASIX group, p=0.001), and increased need for RRT (39% versus 12%, p=0.024. PHO patients with log2-EASIX >2.5 were 6.9 more likely to require vasopressor support [(95% CI 1.7-27.8) p=0.007]. In addition, PHO patients with log2-EASIX >2.5 had longer ICU stay (7 d versus 2 d in the low log2-EASIX group, p=0.024), and extended overall hospitalization (33 d versus 25 d, p=0.029). Conclusion Higher EASIX score was associated with adverse outcomes in critically ill septic PHO patients. Our findings suggest that EASIX score can be used as a tool for identifying septic patients at increased risk of clinical deterioration and poor outcomes. Prospective studies in larger cohorts are warranted to validate and expand upon these findings.
- 2 June 2025
- Published by Wiley
Open AccessEasix score predicts the need for vasopressor support in critically ill pediatric hematology oncology patients
Background Sepsis is a common and serious complication in pediatric hematology oncology (PHO) patients. The Endothelial Activation and Stress Index (EASIX) score offers a potentially accessible tool for risk stratification in septic patients. Our objective was to evaluate the utility of the EASIX score in predicting adverse clinical outcomes among septic PHO patients. Methods Retrospective review of all PHO patients admitted to the intensive care unit (ICU) with sepsis from July 2022 till December 2024. Results 53 patients with 65 sepsis events were included in the analysis. The median age was 14.9 [IQR 9.9] y and the most common disease was hematologic malignancy (71%). In our cohort, 60% needed vasopressor support, 36% required IMV, and 22% underwent renal replacement therapy (RRT). Log2-EASIX >2.5 was associated with higher vasopressor requirements (87% versus 45% in the low log2-EASIX group, p=0.001), and increased need for RRT (39% versus 12%, p=0.024. PHO patients with log2-EASIX >2.5 were 6.9 more likely to require vasopressor support [(95% CI 1.7-27.8) p=0.007]. In addition, PHO patients with log2-EASIX >2.5 had longer ICU stay (7 d versus 2 d in the low log2-EASIX group, p=0.024), and extended overall hospitalization (33 d versus 25 d, p=0.029). Conclusion Higher EASIX score was associated with adverse outcomes in critically ill septic PHO patients. Our findings suggest that EASIX score can be used as a tool for identifying septic patients at increased risk of clinical deterioration and poor outcomes. Prospective studies in larger cohorts are warranted to validate and expand upon these findings.
- 9 December 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (3) , e31473
Continuous Kidney Replacement Therapy in Children With Sinusoidal Obstruction Syndrome After Hematopoietic Cell Transplant: Outcome and Liberation
Background: Sinusoidal obstruction syndrome (SOS), a serious complication after hematopoietic cell transplant (HCT), is associated with multiorgan dysfunction (MOD) and a high mortality rate. In severe cases, continuous kidney replacement therapy (CKRT) is initiated to manage fluid overload (FO) and acute kidney injury. Studies that evaluate the use of CKRT in this population are lacking. The aim of our study was to assess the outcome of critically ill children with severe SOS post HCT who received CKRT. We also sought to assess factors associated with survival and liberation post CKRT.Procedure: Retrospective review of all children admitted to the intensive care unit (ICU) with SOS post HCT who received CKRT from January 2010 to August 2022.Results: Among the 53 children who received CKRT post HCT, 13 had severe SOS. The median age was 6 years; 62% were males, and most (77%) received allogeneic HCT. In this cohort, 92% required respiratory support and 85% required vasopressor support. The ICU survival rate was 62%. Survivors experienced lower cumulative FO on the 2 days following CKRT initiation (−4.2% in survivors vs. −0.5% in non‐survivors, p = 0.07). Higher urine output on D1 and D2 after discontinuation of CKRT was associated with successful liberation.Conclusions: In this study of post‐HCT children with SOS and MOD who received CKRT, 62% survived until ICU discharge. This survival rate is encouraging as it approximates the survival rates of general pediatric cohorts treated with CKRT. Reducing FO after initiation of CKRT can improve survival in these children.
- 9 December 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (3) , e31473
Continuous Kidney Replacement Therapy in Children With Sinusoidal Obstruction Syndrome After Hematopoietic Cell Transplant: Outcome and Liberation
Background: Sinusoidal obstruction syndrome (SOS), a serious complication after hematopoietic cell transplant (HCT), is associated with multiorgan dysfunction (MOD) and a high mortality rate. In severe cases, continuous kidney replacement therapy (CKRT) is initiated to manage fluid overload (FO) and acute kidney injury. Studies that evaluate the use of CKRT in this population are lacking. The aim of our study was to assess the outcome of critically ill children with severe SOS post HCT who received CKRT. We also sought to assess factors associated with survival and liberation post CKRT.Procedure: Retrospective review of all children admitted to the intensive care unit (ICU) with SOS post HCT who received CKRT from January 2010 to August 2022.Results: Among the 53 children who received CKRT post HCT, 13 had severe SOS. The median age was 6 years; 62% were males, and most (77%) received allogeneic HCT. In this cohort, 92% required respiratory support and 85% required vasopressor support. The ICU survival rate was 62%. Survivors experienced lower cumulative FO on the 2 days following CKRT initiation (−4.2% in survivors vs. −0.5% in non‐survivors, p = 0.07). Higher urine output on D1 and D2 after discontinuation of CKRT was associated with successful liberation.Conclusions: In this study of post‐HCT children with SOS and MOD who received CKRT, 62% survived until ICU discharge. This survival rate is encouraging as it approximates the survival rates of general pediatric cohorts treated with CKRT. Reducing FO after initiation of CKRT can improve survival in these children.
- Open Access
- 23 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6348
Fluid Overload in Children Following Hematopoietic Cell Transplant: A Comprehensive Review
Fluid overload significantly increases morbidity and mortality in critically ill children. Following hematopoietic cell transplant (HCT), children are at a high risk of fluid accumulation due to essential increased fluid intake for nutrition, blood products, and antimicrobials. In addition, many complications predispose these children to capillary leak and fluid overload (FO), such as sinusoidal obstruction syndrome, engraftment syndrome, sepsis, and acute kidney injury (AKI). FO > 10% occurs in nearly half of children following HCT and is associated with a lower PICU survival rate. In addition, in children with acute respiratory failure post HCT, each 1% increase in cumulative fluid balance on d 3 increases the odds of PICU mortality by 3%. Furthermore, FO worsens AKI. Tools such as the renal angina index and urinary biomarkers such as neutrophil gelatinase-associated lipocalin can help identify patients at risk of AKI and FO. Early detection, prevention, and intervention are crucial to improving outcomes in this population. Management strategies include fluid restriction, diuretics, and continuous kidney replacement therapy (CKRT) when FO exceeds 10% and other measures have failed.
- 23 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6348
Open AccessFluid Overload in Children Following Hematopoietic Cell Transplant: A Comprehensive Review
Fluid overload significantly increases morbidity and mortality in critically ill children. Following hematopoietic cell transplant (HCT), children are at a high risk of fluid accumulation due to essential increased fluid intake for nutrition, blood products, and antimicrobials. In addition, many complications predispose these children to capillary leak and fluid overload (FO), such as sinusoidal obstruction syndrome, engraftment syndrome, sepsis, and acute kidney injury (AKI). FO > 10% occurs in nearly half of children following HCT and is associated with a lower PICU survival rate. In addition, in children with acute respiratory failure post HCT, each 1% increase in cumulative fluid balance on d 3 increases the odds of PICU mortality by 3%. Furthermore, FO worsens AKI. Tools such as the renal angina index and urinary biomarkers such as neutrophil gelatinase-associated lipocalin can help identify patients at risk of AKI and FO. Early detection, prevention, and intervention are crucial to improving outcomes in this population. Management strategies include fluid restriction, diuretics, and continuous kidney replacement therapy (CKRT) when FO exceeds 10% and other measures have failed.
- Open Access
- 26 September 2024
- Published by Wiley
Continuous Kidney Replacement Therapy in Children with Sinusoidal Obstruction Syndrome After Hematopoietic Cell Transplant: Outcome and Liberation
Background: Sinusoidal obstruction syndrome (SOS), a serious complication after hematopoietic cell transplant (HCT), is associated with multi-organ dysfunction (MOD) and a high mortality rate. In severe cases, continuous kidney replacement therapy (CKRT) is initiated to manage fluid overload (FO) and acute kidney injury. Studies that evaluate the use of CKRT in this population are lacking. The aim of our study was to assess the outcome of critically ill children with severe SOS post HCT who received CKRT. We also sought to assess factors associated with survival and liberation post CKRT. Procedure: Retrospective review of all children admitted to the intensive care unit (ICU) with SOS post HCT who received CKRT from January 2010 to August 2022. Results: Among the 53 children who received CKRT post HCT, 13 had severe SOS. The median age was 6 years; 62% were males, and most (77%) received allogeneic HCT. In this cohort, 92% required respiratory support and 85% required vasopressor support. The ICU survival rate was 62%. Survivors experienced lower cumulative FO on the 2 days following CKRT initiation (-4.2% in survivors versus -0.5% in non-survivors, p=0.07). Higher urine output on D1 and D2 after discontinuation of CKRT was associated with successful liberation. Conclusions: In this study of post-HCT children with SOS and MOD who received CKRT, 62% survived until ICU discharge. This survival rate is encouraging as it approximates the survival rates of general pediatric cohorts treated with CKRT. Reducing FO after initiation of CKRT can improve survival in these children.
- 26 September 2024
- Published by Wiley
Open AccessContinuous Kidney Replacement Therapy in Children with Sinusoidal Obstruction Syndrome After Hematopoietic Cell Transplant: Outcome and Liberation
Background: Sinusoidal obstruction syndrome (SOS), a serious complication after hematopoietic cell transplant (HCT), is associated with multi-organ dysfunction (MOD) and a high mortality rate. In severe cases, continuous kidney replacement therapy (CKRT) is initiated to manage fluid overload (FO) and acute kidney injury. Studies that evaluate the use of CKRT in this population are lacking. The aim of our study was to assess the outcome of critically ill children with severe SOS post HCT who received CKRT. We also sought to assess factors associated with survival and liberation post CKRT. Procedure: Retrospective review of all children admitted to the intensive care unit (ICU) with SOS post HCT who received CKRT from January 2010 to August 2022. Results: Among the 53 children who received CKRT post HCT, 13 had severe SOS. The median age was 6 years; 62% were males, and most (77%) received allogeneic HCT. In this cohort, 92% required respiratory support and 85% required vasopressor support. The ICU survival rate was 62%. Survivors experienced lower cumulative FO on the 2 days following CKRT initiation (-4.2% in survivors versus -0.5% in non-survivors, p=0.07). Higher urine output on D1 and D2 after discontinuation of CKRT was associated with successful liberation. Conclusions: In this study of post-HCT children with SOS and MOD who received CKRT, 62% survived until ICU discharge. This survival rate is encouraging as it approximates the survival rates of general pediatric cohorts treated with CKRT. Reducing FO after initiation of CKRT can improve survival in these children.
- Open Access
- 25 September 2024
- Published by MDPI AG in Preprints.org
Fluid Overload in Children Following Hematopoietic Cell Transplant: A Cause for Concern?
Fluid overload significantly increases morbidity and mortality in critically ill children. Following hematopoietic cell transplant (HCT), children are at high risk of fluid ac-cumulation due to essential increased fluid intake for nutrition, blood products, and antimicrobials. In addition, many complications predispose these children to capillary leak and fluid overload (FO), such as sinusoidal obstruction syndrome, engraftment syndrome, sepsis, and acute kidney injury (AKI). FO>10 % occurs in nearly half of children following HCT and is associated with a lower PICU survival rate. In addition, in children with acute respiratory failure post HCT, each 1% increase in cumulative fluid balance on d 3 increased the odds of PICU mortality by 3%. Furthermore, FO worsens AKI. Tools such as the renal angina index and urinary biomarkers such as neutrophil gelatinase-associated lipocalin can help identify patients at risk of AKI and FO. Early detection, prevention, and intervention are crucial to improving outcome in this population. Management strategies include fluid restriction, diuretics, and continuous kidney replacement therapy (CKRT) when FO exceeds 10% and other measures have failed. Children with FO > 10% at CKRT initiation were 6.16 times more likely to die than were those with FO ≤ 10%.
- 25 September 2024
- Published by MDPI AG in Preprints.org
Open AccessFluid Overload in Children Following Hematopoietic Cell Transplant: A Cause for Concern?
Fluid overload significantly increases morbidity and mortality in critically ill children. Following hematopoietic cell transplant (HCT), children are at high risk of fluid ac-cumulation due to essential increased fluid intake for nutrition, blood products, and antimicrobials. In addition, many complications predispose these children to capillary leak and fluid overload (FO), such as sinusoidal obstruction syndrome, engraftment syndrome, sepsis, and acute kidney injury (AKI). FO>10 % occurs in nearly half of children following HCT and is associated with a lower PICU survival rate. In addition, in children with acute respiratory failure post HCT, each 1% increase in cumulative fluid balance on d 3 increased the odds of PICU mortality by 3%. Furthermore, FO worsens AKI. Tools such as the renal angina index and urinary biomarkers such as neutrophil gelatinase-associated lipocalin can help identify patients at risk of AKI and FO. Early detection, prevention, and intervention are crucial to improving outcome in this population. Management strategies include fluid restriction, diuretics, and continuous kidney replacement therapy (CKRT) when FO exceeds 10% and other measures have failed. Children with FO > 10% at CKRT initiation were 6.16 times more likely to die than were those with FO ≤ 10%.
- Open Access
- 18 August 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1234677
Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies
Introduction: Tumor lysis syndrome (TLS) is often diagnosed in children with hematological malignancies and can be life threatening due to metabolic disturbances. Continuous renal replacement therapy (CKRT) can reverse these disturbances relatively quickly when conventional medical management fails. Our objective was to investigate the benefit of CKRT in the management of TLS in children admitted to the intensive care unit with hematologic malignancies. In addition, we sought to assess risk factors for acute kidney injury (AKI) in the setting of TLS.Methods: Retrospective review of all children admitted to the intensive care unit with TLS who received CKRT from January 2012 to August 2022.Results: Among 222 children hospitalized with TLS from January 2012 to August 2022, 20 (9%) underwent CKRT to manage TLS in the intensive care unit. The patients’ median age was 13 years (range 3-17 y), and most were males (18/20). T-cell acute lymphoblastic leukemia was the most common diagnosis (n=10), followed by acute myeloid leukemia (n=4), Burkitt lymphoma (n=4), and B-cell acute lymphoblastic leukemia (n=2). Five patients required mechanical ventilation, and 2 required vasopressors. The most common indication for CKRT was hyperphosphatemia, followed by, hyperuricemia, and hyperkalemia. All metabolic abnormalities corrected within 12 h of initiation of CKRT. CKRT courses were brief, with a median duration of 2 days (range 1-7 days). Having higher serum phosphorus levels 12 h preceding CKRT was significantly associated with severe acute kidney injury (AKI). The median phosphorus level was 6.4 mg/dL in children with no/mild AKI and 10.5 mg/dL in children with severe AKI (p=0.0375). Serum uric acid levels before CKRT were not associated with AKI. All children survived to hospital discharge, and the one-year survival rate was 90%.Conclusion: CKRT is safe in children with hematologic malignancies with severe TLS and reverses metabolic derangements within 6-12 h. Most patients had AKI at the initiation of CKRT but did not require long-term kidney replacement therapy. Hyperphosphatemia before initiation of CKRT is associated with higher risk of AKI.
- 18 August 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1234677
Open AccessBenefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies
Introduction: Tumor lysis syndrome (TLS) is often diagnosed in children with hematological malignancies and can be life threatening due to metabolic disturbances. Continuous renal replacement therapy (CKRT) can reverse these disturbances relatively quickly when conventional medical management fails. Our objective was to investigate the benefit of CKRT in the management of TLS in children admitted to the intensive care unit with hematologic malignancies. In addition, we sought to assess risk factors for acute kidney injury (AKI) in the setting of TLS.Methods: Retrospective review of all children admitted to the intensive care unit with TLS who received CKRT from January 2012 to August 2022.Results: Among 222 children hospitalized with TLS from January 2012 to August 2022, 20 (9%) underwent CKRT to manage TLS in the intensive care unit. The patients’ median age was 13 years (range 3-17 y), and most were males (18/20). T-cell acute lymphoblastic leukemia was the most common diagnosis (n=10), followed by acute myeloid leukemia (n=4), Burkitt lymphoma (n=4), and B-cell acute lymphoblastic leukemia (n=2). Five patients required mechanical ventilation, and 2 required vasopressors. The most common indication for CKRT was hyperphosphatemia, followed by, hyperuricemia, and hyperkalemia. All metabolic abnormalities corrected within 12 h of initiation of CKRT. CKRT courses were brief, with a median duration of 2 days (range 1-7 days). Having higher serum phosphorus levels 12 h preceding CKRT was significantly associated with severe acute kidney injury (AKI). The median phosphorus level was 6.4 mg/dL in children with no/mild AKI and 10.5 mg/dL in children with severe AKI (p=0.0375). Serum uric acid levels before CKRT were not associated with AKI. All children survived to hospital discharge, and the one-year survival rate was 90%.Conclusion: CKRT is safe in children with hematologic malignancies with severe TLS and reverses metabolic derangements within 6-12 h. Most patients had AKI at the initiation of CKRT but did not require long-term kidney replacement therapy. Hyperphosphatemia before initiation of CKRT is associated with higher risk of AKI.